CIK 0001023549 · Non-accelerated filer
XTL BIOPHARMACEUTICALS LTD
Sign in to watch- Ticker
- XTLB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972 9 955 7080
- Business address
- XTL BIOPHARMACEUTICALS LTD, C/O ALSTON & BIRD LLP, 90 PARK AVENUE, NEW YORK, NY, 10016
- 4 Open-market buy 10% owner bought 2,684,780 shares at an average $3.28 ($8,795,089)
- 4 Open-market buy 10% owner bought 2,065,460 shares at an average $3.77 ($7,785,976)
- 4 Open-market buy 10% owner bought 980,700 shares at an average $3.96 ($3,880,899)
- 4 Open-market buy 10% owner bought 110,000 shares at $4.01 ($441,397)
- 4 Open-market buy 10% owner bought 2,048,000 shares at an average $3.91 ($8,015,605)
- 4 Open-market buy 10% owner bought 463,180 shares at an average $3.91 ($1,811,921)
- 4 Open-market buy 10% owner bought 1,000 shares at $3.84 ($3,840)
- 4 Open-market buy 10% owner bought 6,000 shares at $3.81 ($22,849)
- 4 Open-market buy 10% owner bought 362,000 shares at an average $3.70 ($1,339,890)
- 4 Open-market buy 10% owner bought 942,000 shares at an average $3.85 ($3,626,498)
- 4 Open-market buy 10% owner bought 1,594,000 shares at an average $3.56 ($5,678,874)
- 4 Open-market buy 10% owner bought 250,000 shares at $3.23 ($807,600)
- 4 Open-market buy 10% owner bought 780,000 shares at an average $3.22 ($2,508,660)
- 4 Open-market buy 10% owner bought 200,000 shares at $3.24 ($647,600)
- 4 Open-market buy 10% owner bought 638,570 shares at an average $2.94 ($1,875,164)
- 4 Open-market buy 10% owner bought 2,094,310 shares at an average $3.09 ($6,476,023)
- 4 Open-market buy 10% owner bought 1,413,000 shares at an average $3.10 ($4,379,160)
- 4 Open-market buy 10% owner bought 842,000 shares at an average $3.40 ($2,863,330)
- 4 Open-market buy 10% owner bought 4,311,000 shares at an average $3.21 ($13,818,234)
- 4 Open-market buy 10% owner bought 450,000 shares at an average $3.12 ($1,404,780)
Page 2 of 3 · 49 filings